200 related articles for article (PubMed ID: 28901854)
1. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
Rague A; Tidgewell K
Mini Rev Med Chem; 2018; 18(7):552-560. PubMed ID: 28901854
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors.
Kowalski P; Śliwa P; Satała G; Kurczab R; Bartos I; Zuchowicz K
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28846141
[TBL] [Abstract][Full Text] [Related]
4. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
[TBL] [Abstract][Full Text] [Related]
5. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
Kim J; Kim Y; Tae J; Yeom M; Moon B; Huang XP; Roth BL; Lee K; Rhim H; Choo IH; Chong Y; Keum G; Nam G; Choo H
ChemMedChem; 2013 Nov; 8(11):1855-64. PubMed ID: 24039134
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 5-HT6 receptor ligands based on virtual HTS.
Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
[TBL] [Abstract][Full Text] [Related]
7. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
[TBL] [Abstract][Full Text] [Related]
8. The impact of the halogen bonding on D
Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
[TBL] [Abstract][Full Text] [Related]
9. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P
Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360
[TBL] [Abstract][Full Text] [Related]
10. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
Canale V; Guzik P; Kurczab R; Verdie P; Satała G; Kubica B; Pawłowski M; Martinez J; Subra G; Bojarski AJ; Zajdel P
Eur J Med Chem; 2014 May; 78():10-22. PubMed ID: 24675176
[TBL] [Abstract][Full Text] [Related]
11. Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.
Vermeulen ES; van Smeden M; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
J Med Chem; 2004 Oct; 47(22):5451-66. PubMed ID: 15481983
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT
Penna E; Niso M; Podlewska S; Volpicelli F; Crispino M; Perrone-Capano C; Bojarski AJ; Lacivita E; Leopoldo M
ACS Chem Neurosci; 2022 Feb; 13(4):497-509. PubMed ID: 35099177
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
14. Privileged scaffold-based design to identify a novel drug-like 5-HT
Lacivita E; Niso M; Stama ML; Arzuaga A; Altamura C; Costa L; Desaphy JF; Ragozzino ME; Ciranna L; Leopoldo M
Eur J Med Chem; 2020 Aug; 199():112395. PubMed ID: 32442850
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
Modica MN; Intagliata S; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2015 Apr; 25(7):1427-30. PubMed ID: 25759032
[TBL] [Abstract][Full Text] [Related]
17. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Kurczab R; Romeo G
Bioorg Med Chem; 2017 Feb; 25(3):1250-1259. PubMed ID: 28063784
[TBL] [Abstract][Full Text] [Related]
18. High potent and selective arylpiperazine derivatives as ligands for the 5-HT1A receptor.
Modica M; Santagati M; Santagati A; Russo F; Cagnotto A; Goegan M; Mennini T
Bioorg Med Chem Lett; 2000 May; 10(10):1089-92. PubMed ID: 10843224
[TBL] [Abstract][Full Text] [Related]
19. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
